Gvoke Kit Injection, Solution
Product Images NDC 72065-140

Product Visual Gallery

This gallery contains 67 technical images submitted to the FDA as part of the official labeling for Gvoke Kit (NDC 72065-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xeris Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72065 120 11 Ai Pouch 0.5mg

The label for Gvoke HypoPen 0.5 mg per 0.1 mL glucagon injection shows a single-dose auto-injector intended for low blood sugar emergency use. It includes step-by-step illustrated instructions to prepare, inject, and assist, highlighting the red cap, injection sites on the body, and the auto-injector device with labeled needle end. The product is labeled for Rx only and manufactured by Xeris Pharmaceuticals, Inc.*

FDA Label Image

72065 121 11 Ai Pouch 1mg

Illustrated instructions for using Gvoke HypoPen 1 mg per 0.2 mL glucagon injection auto-injector, showing preparation by tearing open pouch and removing red cap, injection sites on lower abdomen, outer thigh, or outer upper arm, pressing and holding for 5 seconds until window turns red, and assisting patient by laying them on their side and calling emergency help.*

FDA Label Image

72065 130 11 Pfs Pouch 0.5mg

Instructions for Gvoke PFS 0.5 mg per 0.1 mL glucagon injection for low blood sugar emergencies. Steps include preparing by opening the pouch and selecting injection sites on the lower abdomen, outer thighs, or outer upper arm; injecting by pinching skin, inserting the needle at 90 degrees, and pushing the plunger; and assisting by turning the patient on their side and calling emergency medical help. A diagram of the syringe parts is included.*

FDA Label Image

72065 131 11 Pfs Pouch 1mg

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe label from Xeris Pharmaceuticals, Inc. The label includes step-by-step injection instructions for use in low blood sugar emergency, showing preparation, needle insertion at 90 degrees, and patient assistance. Illustrated syringe parts are labeled, including needle cap, needle, viewing window, finger flange, and plunger. The label states the product contains one single-dose pre-filled syringe.*

FDA Label Image

Ai 0.5 mg 1 Pack Carton Label

Gvoke HypoPen 0.5 mg per 0.1 mL glucagon injection single-dose auto-injector carton label by Xeris Pharmaceuticals. The label highlights use for low blood sugar emergency and includes administration instructions with illustrations. Packaging details include storage information and product identification features like barcodes and lot numbers.*

FDA Label Image

Ai 0.5 mg 2 Pack Carton Label

Gvoke HypoPen 0.5 mg per 0.1 mL (glucagon injection) single-dose auto-injector carton from Xeris Pharmaceuticals, Inc. The label shows it is intended for low blood sugar emergency, contains 2 single-dose auto-injectors, and provides instructions for use with illustrations of the auto-injector and injection steps. Storage and usage warnings are included.*

FDA Label Image

Ai 0.5 mg Device Label

Label for Gvoke HypoPen glucagon injection, strength 0.5 mg per 0.1 mL. This single-dose auto-injector is for subcutaneous use only and manufactured by Pyramid Laboratories, Inc. for Xeris Pharmaceuticals, Inc.*

FDA Label Image

Ai 0.5 mg Pouch Label

Gvoke HypoPen 0.5 mg per 0.1 mL (glucagon injection) label for a single-dose auto-injector. The label includes instructions for subcutaneous use in low blood sugar emergencies, manufacturer information for Xeris Pharmaceuticals, and visual step-by-step injection guidance with illustrations, indicating injection sites and use directions.*

FDA Label Image

Ai 1 mg 1 Pack Carton Label

Packaging label for Gvoke HypoPen (glucagon injection) 1 mg per 0.2 mL single-dose auto-injector by Xeris Pharmaceuticals. The label highlights use for low blood sugar emergency and contains one single-dose auto-injector. Instructions with illustrations for preparing, injecting, and assisting the patient are included. The label displays storage information and safety instructions.*

FDA Label Image

Ai 1 mg 2 Pack Carton Label

Packaging label for Gvoke HypoPen (glucagon injection) 1 mg per 0.2 mL single-dose auto-injector by Xeris Pharmaceuticals. The carton contains 2 single-dose auto-injectors for subcutaneous use, indicated for low blood sugar emergency. Instructions for preparing, injecting, and assisting the patient are illustrated on the label. The label includes storage information and a depiction of the auto-injector device.*

FDA Label Image

Ai 1 mg Device Label

Label for Gvoke HypoPen glucagon injection, showing strength of 1 mg per 0.2 mL. It is a single-dose auto-injector intended for subcutaneous use only. The label indicates the needle end direction and includes placeholder text for lot and expiration date. Manufactured by Pyramid Laboratories, Inc. for Xeris Pharmaceuticals, Inc., Chicago, IL.*

FDA Label Image

Ai 1 mg Pouch Label

The Gvoke HypoPen label for glucagon injection shows a 1 mg per 0.2 mL single-dose auto-injector for subcutaneous use. The label highlights usage for low blood sugar emergencies and is manufactured for Xeris Pharmaceuticals, Inc. It includes storage instructions and a barcode.*

FDA Label Image

Figure A

An instructional illustration showing the contents of a package for Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc. The image depicts a pre-filled syringe vial and a sealed rectangular package inside an open box, with arrows indicating these items are included in the packaging.*

FDA Label Image

Figure B

An instructional illustration showing a vial with a label pointing to the expiration date area, indicated by the text 'EXP YYYY MM.' An eye icon suggests checking the expiration date before use.*

FDA Label Image

Figure C

An instructional illustration showing a vial of medication with a close-up detail of a human eye, indicating attention or caution when administering the product. The image suggests careful inspection or application related to the vial content.*

FDA Label Image

Figure D

Illustration showing a hand removing a protective cap from the vial of a Gvoke PFS 0.5 mg pre-filled syringe, demonstrating the initial step to prepare the injection.*

FDA Label Image

Figure E

An illustration from Gvoke PFS 0.5 mg Pre-filled Syringe showing a hand peeling back a protective adhesive strip from a surface, indicating a step in device preparation or use.*

FDA Label Image

Figure F

An instructional illustration showing the removal of the red cap from the needle of a pre-filled syringe. The image demonstrates the proper technique using one hand to hold the syringe and the other to pull off the cap in an upward motion.*

FDA Label Image

Figure G

Instructional illustration showing the proper method of using a pre-filled syringe, specifically demonstrating how to press the syringe plunger down into a vial with one hand while holding the vial steady with the other. This image supports understanding of the Gvoke PFS 0.5 mg Pre-filled Syringe usage.*

FDA Label Image

Figure H

An instructional diagram showing the removal of a cap from a pre-filled syringe. The image depicts a hand holding the syringe and another hand rotating the cap counterclockwise to remove it.*

FDA Label Image

Figure J

An illustration showing a front and back view of a human torso with highlighted injection sites. The front view highlights the lower abdomen and outer thighs, while the back view highlights the outer upper arms. This diagram indicates appropriate injection sites for the medication.*

FDA Label Image

Figure K

An instructional illustration showing areas for exposing skin before injection. It depicts a person lifting their shirt on one side and pointing to their outer thigh on the opposite leg as potential injection sites for Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Figure L

An instructional illustration showing a hand pinching a portion of skin, likely preparing an injection site. The drawing depicts the thumb and index finger grasping the skin to raise a small fold.*

FDA Label Image

Figure M

An instructional illustration showing a hand holding a pre-filled syringe oriented vertically at 90 degrees, with the needle tip positioned just above the skin of another person's arm, demonstrating the injection angle for the Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Figure N

An instructional illustration showing a hand holding a syringe, positioning the needle perpendicular to the skin surface of another person's arm. A downward arrow indicates the direction for injection. This diagram likely demonstrates the proper technique for administering an injection with the Gvoke PFS pre-filled syringe.*

FDA Label Image

Figure O

An instructional illustration showing a hand holding a syringe inserted under the skin, with an arrow pointing upward indicating the syringe is being pulled out after injection.*

FDA Label Image

Figure P

Illustration showing a person positioned on their side in a recovery position, turning the head slightly backward, presumably to maintain an open airway. This type of image typically demonstrates first aid or emergency care positioning.*

FDA Label Image

Figure Q

An instructional illustration showing a hand holding a syringe above a red sharps container labeled 'SHARPS CONTAINER,' with a black downward arrow indicating disposal of the syringe into the container.*

FDA Label Image

Full Image

Illustration showing the components of Gvoke PFS 0.5 mg Pre-filled Syringe. It includes a vial with a blue cap, a syringe composed of a plunger, syringe body, and needle, and a separate needle cap. The note indicates that each vial and syringe is single-use and should be discarded after one use.*

FDA Label Image

One Syringe Both Doses

An illustration of a pre-filled syringe showing two volume markings: 0.1 mL labeled for Pediatric Dose and 0.2 mL labeled for Adult Dose. The graphic highlights dosing volumes for Gvoke PFS 0.5 mg pre-filled syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Pfs 0.5 mg 1 Pack Carton Label

Packaging label for Gvoke PFS 0.5 mg per 0.1 mL glucagon injection, a single-dose pre-filled syringe by Xeris Pharmaceuticals, Inc. The label highlights use for low blood sugar emergency and includes instructions for preparing, injecting, and assisting after injection. The syringe image and part names like needle cap, needle, finger flange, and plunger are shown.*

FDA Label Image

Pfs 0.5 mg 2 Pack Carton Label

Gvoke PFS 0.5 mg per 0.1 mL pre-filled syringe carton by Xeris Pharmaceuticals, Inc. The label shows glucagon injection for low blood sugar emergency, containing 2 single-dose pre-filled syringes. Instructions for subcutaneous use, storage conditions, and disposal guidance appear. The label also features detailed step-by-step injection instructions with images and a syringe diagram labeling parts like needle, plunger, and finger flange.*

FDA Label Image

Pfs 0.5 mg Device Label

Label for Gvoke PFS (glucagon injection) 0.5 mg per 0.1 mL pre-filled syringe. The label indicates the product is for subcutaneous use only and includes placeholder text for lot number and expiration date. The labeler is Xeris Pharmaceuticals, Inc.*

FDA Label Image

Pfs 0.5 mg Pouch Label

Gvoke PFS 0.5 mg per 0.1 mL glucagon injection pre-filled syringe label by Xeris Pharmaceuticals, Inc. The label includes usage instructions for subcutaneous injection for low blood sugar emergency, storage information at controlled room temperature, and disposal guidance. It shows manufacturer details, barcode, and warnings not to refrigerate or freeze the product.*

FDA Label Image

Pfs 1 mg 1 Pack Carton Label

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe carton label for glucagon injection by Xeris Pharmaceuticals, Inc. The label includes product name, strength, and dosage form, a red warning for low blood sugar emergency, usage instructions with illustrations, and storage and disposal information. The label also shows a syringe diagram indicating parts such as needle, needle cap, plunger, and viewing window.*

FDA Label Image

Pfs 1 mg 2 Pack Carton Label

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe carton by Xeris Pharmaceuticals, Inc. The glucagon injection is indicated for low blood sugar emergency. The package contains 2 single-dose pre-filled syringes for subcutaneous use. The label includes preparation, injection, and assistance instructions with illustrations, storage guidelines, and a product image showing the syringe.*

FDA Label Image

Pfs 1 mg Device Label

Label for Gvoke PFS (glucagon injection) pre-filled syringe, strength 1 mg per 0.2 mL, indicated for subcutaneous use only. The label includes placeholders for lot number and expiration date and identifies the manufacturer as Xeris Pharmaceuticals, Inc.*

FDA Label Image

Pfs 1 mg Pouch Label

The image shows front and back labels for Gvoke PFS 1 mg per 0.2 mL (glucagon injection) pre-filled syringe by Xeris Pharmaceuticals, Inc. The front label highlights its use for low blood sugar emergency and contains storage and usage warnings. The back label provides step-by-step illustrated instructions for preparing, injecting, and assisting the patient with the syringe.*

FDA Label Image

Its Molecular Formula Is C153h225n43o49s With The Following Structure: (Image 01)

Chemical structure diagram displaying a peptide sequence consisting of 29 amino acids with their standard three-letter codes and positions, representing the active ingredient in a pharmaceutical product.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting mean plasma glucose levels (mg/dL) over time (minutes) following administration of 1 mg Gvoke PFS. The graph displays data points with error bars from 0 to 90 minutes, showing a rise in glucose levels throughout the period.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing mean plasma glucose (mg/dL) over time (minutes) after administration of Gvoke PFS. It compares three age groups: 2 to under 6 years and 6 to under 12 years each receiving 0.5 mg, and 12 to under 18 years receiving 1 mg. Data include error bars representing variability across subjects.*

FDA Label Image

Figure 3 (Image 04)

A line graph showing mean glucagon concentration (pg/mL) over time (minutes) from injection of 1 mg Gvoke. The graph indicates a glucagon concentration peak around 30-40 minutes post-injection, followed by a gradual decline over 240 minutes. Error bars represent variability among 78 subjects.*

FDA Label Image

Figure 4 (Image 05)

A line graph showing mean glucagon levels (pg/mL) over time (minutes) from injection for three age groups after Gvoke injection. The groups include ages 2 to under 6 years with a 0.5 mg dose, ages 6 to under 12 years with a 0.5 mg dose, and ages 12 to under 18 years with a 1 mg dose. The glucagon levels peak around 20 to 40 minutes and then decline, with error bars indicating variability.*

FDA Label Image

Ai Image (Image 08)

An instructional illustration of the Gvoke PFS pre-filled syringe showing its components: a red cap, needle end, yellow needle guard, and a medication viewing window on the syringe barrel.*

FDA Label Image

Ifua-sideb-f1 (Image 09)

Instructional illustration showing two steps for using the Gvoke PFS pre-filled syringe. Figure 1 depicts a hand removing a protective strip from the packaging, and the next image shows a hand pulling the pre-filled syringe from the box, indicating how to prepare the syringe for use.*

FDA Label Image

Ifua-sideb-f2 (Image 10)

An instructional diagram showing how to check the expiration date on the side of a Gvoke PFS pre-filled syringe. The image highlights an eye focusing on the area labeled 'EXP: YYYY MM' indicating where the expiration date is printed on the syringe.*

FDA Label Image

Ifua-sideb-f3 (Image 11)

Instructional illustration showing a hand holding the Gvoke PFS pre-filled syringe and focusing on the viewing window. An enlarged eye icon points to the window, indicating the need to visually check the medication inside before use.*

FDA Label Image

Ifua-sideb-f4 (Image 12)

Instructional diagram showing a hand pulling off a red cap from a syringe, with a black arrow indicating the motion. The text "Pull Off Red Cap" is displayed below the image. This figure is part of the Gvoke PFS pre-filled syringe instructions.*

FDA Label Image

Ifua-sideb-f5 (Image 13)

An instructional diagram showing recommended injection sites for Gvoke PFS pre-filled syringe on the front and back views of a human body, highlighting areas on the abdomen, thighs, and upper arms. Another illustration demonstrates how to expose the skin of the injection site by lifting a shirt and adjusting shorts.*

FDA Label Image

Ifua-sideb-f6 (Image 14)

An instructional diagram showing how to use the Gvoke PFS 0.5 mg Pre-filled Syringe. Figure 7 depicts pushing and holding the syringe against the skin until a "click" sound, followed by holding down for 5 seconds. Figure 8 shows a close-up of the viewing window on the syringe indicating successful administration by a visible red indicator.*

FDA Label Image

Ifua-sideb-f7 (Image 15)

An instructional illustration showing how to use the Gvoke PFS pre-filled syringe. It depicts a hand lifting the syringe vertically away from the skin after injection, highlighting that the yellow needle guard locks over the needle to ensure safety.*

FDA Label Image

Ifua-sideb-f8 (Image 16)

Illustration showing a person lying down and rolling onto their side. The figure is labeled "Figure 10" and depicts the action of turning the body to the side, likely as part of a usage or safety instruction.*

FDA Label Image

Ifua-sideb-f9 (Image 17)

An instructional illustration showing the proper disposal of a syringe. One inset depicts removing a red cap from a Gvoke PFS pre-filled syringe. The main image shows a hand placing the used syringe into a labeled sharps container. This figure emphasizes safe syringe disposal procedures.*

FDA Label Image

Pfs Image (Image 20)

An instructional diagram showing the components of a pre-filled syringe, including needle cap, needle, viewing window/syringe body, finger flange, and plunger, illustrating the assembly and parts of the syringe device.*

FDA Label Image

Ifub-sideb-f1 (Image 21)

Instructional illustration showing the first two steps of using the Gvoke PFS pre-filled syringe. Figure 1 depicts peeling off the label cover from the syringe. The next panel shows pressing the syringe plunger to inject the medication. The images focus on hand positioning and syringe handling.*

FDA Label Image

Ifub-sideb-f2 (Image 22)

An instructional illustration showing a hand holding the Gvoke PFS pre-filled syringe with a focus on the expiration date label on the syringe barrel. The image emphasizes locating and reading the expiration date on the syringe.*

FDA Label Image

Ifub-sideb-f3 (Image 23)

An instructional illustration showing hands holding a Gvoke PFS pre-filled syringe with a focus on the syringe tip aligned with an eye. The diagram likely demonstrates the proper method for administering the injection, emphasizing eye-level alignment for correct use.*

FDA Label Image

Ifub-sideb-f4 (Image 24)

Instructional diagrams showing injection site selection for Gvoke PFS 0.5 mg pre-filled syringe. The front and back views highlight recommended skin areas on the abdomen, thighs, and upper arms for subcutaneous injection. An additional illustration shows how to expose the skin by lifting a shirt and pulling down shorts or pants to prepare the injection site.*

FDA Label Image

Ifub-sideb-f5 (Image 25)

An instructional illustration showing a hand pulling off the needle cap from a pre-filled syringe, labeled as Figure 6, as part of the usage directions for Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Ifub-sideb-f6 (Image 26)

Instructional illustration showing the steps for using a pre-filled syringe. It depicts pinching the skin, inserting the syringe at a 90-degree angle, and pushing the plunger to inject the medication.*

FDA Label Image

Ifub-sideb-f7 (Image 27)

An instructional illustration showing a hand holding a pre-filled syringe being used to inject into the skin, with an arrow indicating the upward removal of the syringe after injection. The image is labeled as Figure 10.*

FDA Label Image

Ifub-sideb-f8 (Image 28)

Illustration showing a person rolling onto their side, as indicated by an arrow and text 'Roll Onto Side'. This is a two-frame instructional diagram depicting a step of moving from lying on the back to lying on the side.*

FDA Label Image

Ifub-sideb-f9 (Image 29)

Illustration depicting safe disposal of a syringe into a sharps container. A hand holds a syringe above a red sharps container labeled with a biohazard symbol and 'SHARPS CONTAINER,' with an arrow indicating the syringe is to be inserted into the container.*

FDA Label Image

Kit Carton Side 1

The packaging label for Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc. The kit is labeled as glucagon injection with a single-dose vial and syringe containing 1 mg per 0.2 mL. The label prominently states the product is for low blood sugar emergency and instructs to discard unused portions. The label includes dosage information and storage instructions, barcode, NDC 72065-140-11, and clear visual illustrations of the vial and syringe components.*

FDA Label Image

Kit Carton Side 2

Gvoke Kit packaging label for glucagon injection, containing instructions and dosage information. The label indicates a strength of 1 mg per 0.2 mL, with step-by-step visual guides for preparation, dosing, injection, assistance, and disposal. Labeler is Xeris Pharmaceuticals, Inc.*

FDA Label Image

Pouch

This image shows a text panel containing usage instructions and storage information for Gvoke PFS 0.5 mg Pre-filled Syringe. It includes details about the syringe specifications (29 gauge x 1/2 inch needle), dosage directions, warnings against reuse and latex presence, and manufacturer details by Xeris Pharmaceuticals, Inc. The panel also includes placeholders for lot and expiration dates.*

FDA Label Image

Vial

Gvoke Kit glucagon injection label showing 1 mg per 0.2 mL strength. It is a single-dose vial for subcutaneous use, with instructions to discard unused portion and protect from light exposure. Manufactured by Pyramid Laboratories, Inc. for Xeris Pharmaceuticals, Inc., Chicago, IL. Includes barcode, NDC 72065-141-11, and lot/expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.